Provayblue: payments to doctors
Payments that named Provayblue as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $150K
- Providers
- 4
- Transactions
- 24
- Average per transaction
- $6,234
The per-transaction average — $6,234 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $37,403, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Provepharm Inc. | $149,611 | 100.0% |